Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma

ClinicalTrials.gov ID: NCT00096616

Public ClinicalTrials.gov record NCT00096616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 1:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Dose, Randomized, Double-blind Crossover Comparison of Combivent CFC MDI and Albuterol HFA MDI in Patients With Moderate to Severe Persistent Asthma and Persistent Symptoms Despite Treatment With Inhaled Corticosteroids

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to demonstrate the superior bronchodilator efficacy of inhaled Combivent® CFC MDI vs. Albuterol HFA MDI in moderate to severe asthma patients.

Study identification

NCT ID
NCT00096616
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
113 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2004 (Type not available)
Primary completion
Mar 2006 (Actual)
Completion
Not listed
Last update posted
Nov 1, 2013

Started 2004

United States locations

U.S. sites
27
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
620 South 20th Street, NHB 104 Birmingham Alabama — —
Cooper Green Hospital Birmingham Alabama — —
Southern California Clinical Trials Lakewood California — —
Boehringer Ingelheim Investigational Site Palmdale California — —
Boehringer Ingelheim Investigational Site Wheat Ridge Colorado — —
Norwalk Hospital Norwalk Connecticut — —
University of Miami School of Medicine Miami Florida — —
Boehringer Ingelheim Investigational Site Panama City Florida — —
Boehringer Ingelheim Investigational Site Coeur d'Arlene Idaho — —
Boehringer Ingelheim Investigational Site River Forest Illinois — —
Boehringer Ingelheim Investigational Site Olathe Kansas — —
LSU MC-Sheveport Shreveport Louisiana — —
Boehringer Ingelheim Investigational Site Auburn Maine — —
Johns Hopkins Asthma & Allergy Baltimore Maryland — —
Brigham & Women's Hospital Boston Massachusetts — —
Boehringer Ingelheim Investigational Site Berlin New Jersey — —
Boehringer Ingelheim Investigational Site Cherry Hill New Jersey — —
North Shore University Hospital Manhasset New York — —
NYU School of Medicine New York New York — —
Division of Pulmonary & Critical Care Medicine Durham North Carolina — —
Wake Forest University, Center for Human Genomics Winston-Salem North Carolina — —
Penn State University, Hershey Medical Center Hershey Pennsylvania — —
Boehringer Ingelheim Investigational Site Charleston South Carolina — —
Spartanburg Medical Research Spartanburg South Carolina — —
Ben Taul General Hospital Houston Texas — —
University of Texas Health Center at Tyler Tyler Texas — —
University of Wisconsin Hospital Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00096616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2013 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00096616 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →